Lotus Pharmaceuticals, Inc.

Lotus Pharmaceuticals, Inc.

LTUS
Lotus Pharmaceuticals, Inc.US flagOther OTC
0.00
USD
- -
- -
82,311.00Market Cap

Valuation

Price vs. fair value · multiples
Price & Valuation BandSIGNATURE
Price against a fair-value channel (EPS × 12 / 15 / 23×)
Undervalued -100%
PriceFair value

Growth

Revenue · EPS · free cash flow
Revenue
Top line with YoY growth
+31.7% CAGR
RevenueYoY growth
EPS (Diluted)
Per-share earnings · loss years read red
+23.9% CAGR
EPSYoY growth
Free Cash Flow
Operating CF − capex, with FCF margin
Operating CFCapexFree cash flowFCF margin

Profitability

Margins & returns on capital
Gross Profit & Margin
Bars with margin trend line
+60.3% CAGR
Gross profitGross margin
Operating Income & Margin
Bars with margin trend line
+103.4% CAGR
Operating incomeOperating margin
Net Income & Margin
Loss years read red
+51.1% CAGR
Net incomeNet margin
ROIC · ROE · ROA
Returns on capital · ROE on right axis
ROICROEROA

Balance Sheet Health

Liquidity · leverage · share count
Cash vs. Debt
Liquidity & leverage, net-debt line
Cash & investmentsTotal debtNet debt
Shares Outstanding
Diluted share count · buybacks vs. dilution
+21.9% CAGR
Dividends & Payout Ratio
Dividend per share with payout overlay
No data available

Dividends & Payout Ratio isn’t reported for LTUS.

roic.ai · Fundamentals charts. Figures are not investment advice.